Bogdahn, Ulrich

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 21,807

Changes in grey matter induced by training

Draganski, B., Gaser, C., Busch, V., Schuierer, G., Bogdahn, U., & May, A. (2004) · Nature

Motor Control and AdaptationAdvanced Neuroimaging Techniques and Applications

Cited by 2,373

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., et al. (2011) · Neuro-Oncology

Glioma Diagnosis and TreatmentOvarian cancer diagnosis and treatment

Cited by 433

Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients

Schmidt-Wilcke, T., Leinisch, E., Gänbauer, S., Draganski, B., Bogdahn, U., Altmeppen, J., & May, A. (2006) · Pain

Pain Mechanisms and TreatmentsPain Management and Treatment

Cited by 413

Targeted tumor therapy with the TGF-β2 antisense compound AP 12009

SCHLINGENSIEPEN, K., SCHLINGENSIEPEN, R., STEINBRECHER, A., HAU, P., BOGDAHN, U., FISCHERBLASS, B., & JACHIMCZAK, P. (2006) · Cytokine & Growth Factor Reviews

TGF-β signaling in diseasesGlioma Diagnosis and Treatment

Cited by 195

The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma

Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dörries, R., Schlingensiepen, K.-H., & Brysch, W. (1993) · Journal of Neurosurgery

TGF-β signaling in diseasesGlioma Diagnosis and Treatment

Cited by 146